Redox proteomic identification of carbonylated proteins in autism plasma: insight into oxidative stress and its related biomarkers in autism
3 Multiple REDEFINE clinical trials are currently underway including: REDEFINE 3, an event-driven cardiovascular outcomes phase 3 trial
Gevezova M, Minchev D, Pacheva I, Todorova T, Yordanova R, Timova E, Ivanov I, Sarafian V (2022) Association of NGF and mitochondrial respiration with autism spectrum disorder
Over time, healthier skin cells reach the surface, giving the skin a fresher and more refined look
Harnessing selenocysteine reactivity for oxidative protein folding
Every vial is independently verified to 99% purity by third-party HPLC, lyophilised for stability, and shipped same-day with cold-pack packaging anywhere in Canada